With more than half of the 16 teams still mathematically alive to make the conference championship game, the Big 12 will command a lot of attention in the final week of the regular season. No. 14 Arizona State and No. 17 Iowa State would play for the Big 12 title and likely College Football Playoff spot on Dec. 7 if they both win Saturday and there's a four-way tie for first place. There are seven other teams that begin this week with hopes, slim in most cases, of getting into the game at AT&T Stadium in Arlington, Texas. Last week it was No. 19 BYU and No. 23 Colorado that had the inside track to the championship game. Arizona State beat the Cougars and Kansas knocked off the Buffaloes, and here we are. "Everybody counted us out, I think, two weeks ago," Iowa State coach Matt Campbell said after his team beat Utah 31-28. "We didn't flinch. We didn't waver. And we just keep fighting." The Cyclones were national darlings the first half of the season as they won seven straight games to match the best start in program history. Back-to-back losses to Texas Tech and Kansas followed. Now they've won two straight heading into "Farmageddon," their rivalry game against Kansas State at home. "Right now they've got the pen and they continue to write the story," Campbell said of his players, "and I hope they will continue to write it the way they've got the ability to write it. Unwavering. Tough, mentally tough, physically tough. This group has stood for it every step of the way." Arizona State has been an even better story than the Cyclones. The Sun Devils have six more wins than they did last season, when they went 3-9. They were picked to finish last in their first year in the Big 12. They'll go for their fifth straight victory when they play at Arizona on Saturday. "These guys came off no momentum and everybody doubting them, and everybody is still doubting them. That's what makes this special," second-year coach Kenny Dillingham said. "Hopefully the expectations become higher. I don't know if there's a way we can exceed expectations more than we're exceeding them right now." Checking in on five of the Top 25: The Ducks were idle Saturday after clinching a spot in the Big Ten championship game with their win at Wisconsin on Nov. 16. Oregon can go 12-0 in the regular season for the first time since 2010 if it beats Washington at home this week. Oregon's only two losses last season came against the Huskies, both decided by three points. The first was a top-10 matchup in the regular season and the second was a top-five matchup in the Pac-12 championship game. The Ducks are 19 1/2-point favorites this time, according to BetMGM Sportsbook. The Buckeyes' showdown with upstart Indiana combined with Michigan's dropoff after winning the national championship have lowered the volume on this week's meeting with the Wolverines at the Horseshoe. If Michigan beats Ohio State a fourth straight time and it keeps the Buckeyes out of the Big Ten championship game and playoff ... well, there'll be lots of noise in Columbus then. The Lone Star Showdown returns to the gridiron for the first time since 2011, when Texas and Texas A&M were in the Big 12. The Longhorns head to No. 20 Texas A&M on a four-game win streak. The Aggies have lost two of three after Saturday's four-overtime loss at Auburn. The winner advances to the Southeastern Conference championship game against Georgia. The Broncos are tied with Notre Dame for the second-longest active win streak, at nine games, and they seem to have adopted a survive-and-advance mantra. They trailed 23-point underdog Wyoming in the fourth quarter before winning 17-13 and clinching a spot in the Mountain West championship game. They won their previous game, 42-21 against San Jose State, but didn't pull away until the fourth quarter. Two weeks ago they beat a three-win Nevada team 28-21. Just when you think Illinois is about to cash in for the season, they do what they did against Rutgers. The Illini were down 31-30 when they lined up for a 58-yard field goal with 14 seconds left. Ethan Moczulski missed. But wait. Rutgers called timeout before the snap, and Bret Bielema thought better of trying another kick and sent his offense back on the field. Luke Altmyer passed to Pat Bryant for the winning 40-yard touchdown. The Illini won't play for the Big Ten title, but they have a chance for nine wins and a nice bowl. Ohio State played in three of the five regular-season top-five matchups and won three of them. The Buckeyes lost to Oregon and beat Penn State and Indiana. ... Kansas' 37-21 win over Colorado made the Jayhawks the first FBS team with a losing record to beat three straight Top 25 opponents. The Jayhawks, who were 2-6 a month ago, will be bowl eligible if they win at Baylor. ... Nebraska ended the longest power conference bowl drought with its 44-25 win over Wisconsin. The Cornhuskers haven't played in a bowl since 2016. Get local news delivered to your inbox!
It’s certainly not everyday the lead vocalist of a rock band transitions into becoming one of the great movie composers of our time, but Trent Reznor and Atticus Ross have done so with their careers in music. While the musicians initially gained fame for being Nine Inch Nails, since 2010, they’ve been scoring tons of movies, from The Social Network to two great 2024 movies , Challengers and Queer . While talking about their recent work, Reznor got honest about why he prefers making music for movies. Trent Reznor and Atticus Ross have managed to balance their work in Nine Inch Nails with their work in movies over nearly 15 years. Here’s what Reznor said about why he has a clear favorite between the music and movie industry: What we’re looking for [from film] is the collaborative experience with interesting people. We haven’t gotten that from the music world necessarily, for our own choice. You mentioned disillusionment with the music world? Yes. The culture of the music world sucks. That’s another conversation, but what technology has done to disrupt the music business in terms of not only how people listen to music but the value they place on it is defeating. I’m not saying that as an old man yelling at clouds, but as a music lover who grew up where music was the main thing. Music [now] feels largely relegated to something that happens in the background or while you’re doing something else. That’s a long, bitter story. While speaking to Reznor, IndieWire shared his frustration for the music industry, which has certainly changed quite a bit in the age of the internet and social media. The 59-year-old recalls a time when the music industry was centered on the art itself, but no longer feels that way anymore. While he ultimately deflected diving deeper into his thoughts on the topic, he clearly isn’t high on the state of things considering his flat-out “the music world sucks” comments. While Reznor may feel out of place in the music industry, his and Atticus Ross’ work in Hollywood has definitely paid off. They’ve become well-known for their unconventional movie scores , such as for The Social Network which won Best Original Score in 2011. Reznor and Ross also earned their second Oscar in the category for Soul in 2021. When it comes to their latest works, both in Luca Guadagnino films, Challengers is especially in conversation during awards season and could make for the team’s fourth nomination in the category of Best Original Score. When speaking about the making of it, Reznor said this: With Challengers, it was much more, right off the bat, he came to us and said, ‘I think music should be a character in the film. It should be unavoidable. It should be propelling. I want the audience to feel like they can dance in their seats to the whole thing like it’s a fucking rave. I want it to be aggressive. I want to make the movie fun.’ OK, let’s see what happens. By the time Challengers was brought to Reznor and Ross, the duo had worked with the director once before on 2022’s Bones And All . They said that along with Guadagnino wanting the movie’s bold music to be a character in the movie, he also directed them to club music out of Berlin to inform his vision. Considering our Challengers review and the score’s current momentum to go down as one of the best scores of 2024, we’d say it worked! Reznor and Ross’s latest collaboration with Luca Guadagnino has arrived, with the Queer release date now here. Check it out in theaters and stream Challengers with an Amazon Prime Video subscription . CINEMABLEND NEWSLETTER Your Daily Blend of Entertainment NewsNone
The Nothing Phone (1) as well as Phone (2a) Plus are the latest two devices that get the Android 15-based Nothing OS 3.0 Open Beta 1. The CMF Phone 1 earlier received the Nothing OS 3.0 Open Beta 1. The update changelog for both the Nothing Phone (1) and Phone (2a) Plus remain the same. Through the latest update (Open Beta 1) both the devices get Camera Improvements, Shared Widgets, an AI-powered Smart Drawer, and a new lock screen customization page. The update includes the following features Use widgets to link up with friends and family. See another person’s widgets displayed on your home screen and interact with each other through reactions. A new way to stay connected. Note: This is a Beta version and the test software can interfere with your data and might require a factory reset. Interested users who plan to install the update should back up all their data.
Lyophilized Injectable Drugs Market Size: Strong Growth Ahead (2024-2032) 12-25-2024 03:21 PM CET | Health & Medicine Press release from: Cognate Insights Lyophilized Injectable Drugs Market Latest Market Overview The global lyophilized injectable drugs market is projected to reach USD 75 billion in 2024, growing at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2032. Lyophilized injectable drugs, which are commonly used for biologics, vaccines, and monoclonal antibodies, are gaining significant traction due to their ability to maintain the stability and potency of sensitive therapeutic agents. The increasing prevalence of chronic diseases, the growing demand for biologics, and advancements in drug formulation and delivery methods are the primary drivers of the market. Additionally, lyophilization offers a cost-effective and efficient way to store and transport injectable drugs, further boosting market adoption. The Lyophilized Injectable Drugs Market has experienced steady growth in recent years and is expected to continue expanding at a strong pace from 2024 to 2032. This analysis offers a comprehensive overview, providing valuable insights into key trends and developments within the Lyophilized Injectable Drugs industry. These findings equip business leaders with the necessary knowledge to devise more effective strategies and enhance profitability. Furthermore, the report serves as a useful resource for new and emerging businesses, helping them make informed decisions as they navigate the market and seek growth opportunities. Major Players of Lyophilized Injectable Drugs Market are: SP Industries (New Jersey, USA) - USD 1.2 billion revenue in 2023 GEA Group (Düsseldorf, Germany) - USD 5.5 billion revenue in 2023 IMA Group (Bologna, Italy) - USD 2.3 billion revenue in 2023 Labconco Corporation (Missouri, USA) - USD 680 million revenue in 2023 Tofflon Science and Technology (Shanghai, China) - USD 1 billion revenue in 2023 Get Latest PDF Sample Report @ https://www.cognateinsights.com/request-sample/lyophilized-injectable-drugs-market-research Our Report covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2032 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets. Global Lyophilized Injectable Drugs Market Landscape and Future Pathways: North America: United States Canada Europe: Germany France U.K. Italy Russia Asia-Pacific: China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America: Mexico Brazil Argentina Korea Colombia Middle East & Africa: Turkey Saudi Arabia UAE Korea Speak to Our Analyst for A Discussion on The Above Findings, And Ask for A Discount on The Report @ https://www.cognateinsights.com/check-discount/lyophilized-injectable-drugs-market-research Key drivers and challenges influencing the Lyophilized Injectable Drugs market: Regional Analysis: The report involves examining the Lyophilized Injectable Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets. Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Lyophilized Injectable Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends. Company Analysis: Report covers individual Lyophilized Injectable Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies. Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Lyophilized Injectable Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application. Technology Analysis: Report covers specific technologies relevant to Lyophilized Injectable Drugs. It assesses the current state, advancements, and potential future developments in Lyophilized Injectable Drugs areas. Reason to Buy this Report: -Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years. -Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants. -Overview of the competitive landscape in the Lyophilized Injectable Drugs market, including profiles of the key players, their market share, and strategies for growth. -Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. -Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. For In-Depth Competitive Analysis - Purchase this Report now at @ https://www.cognateinsights.com/purchase-report/lyophilized-injectable-drugs-market-research Contact Us: Cognate Insights Web: www.cognateinsights.com Email: info@cognateinsights.com Phone: +91 8424946476 About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.
您将承担一切因您的行为、言论而直接或间接导致的民事或刑事法律责任。
留言板管理人员有权保留或删除其管辖留言中的任意内容。
本站提醒:不要进行人身攻击。谢谢配合。
yugioh online game 版权所有,未经授权禁止转载,复制或者建立镜像。违者追究责任
声明:本站呈现的所有资料均由yugioh online game 工作团队编辑发布,版权所有,严禁窃为己作;未经授权切勿转载或建立镜像。否则本站保留追究法律责任的权利。
Copyright © 2018 Tencent. All Rights Reserved